Welcome to agile manufacturing!
In regulated industries, every day of delay costs real money. While the market demands speed, rigid EBR/MES systems slow down your innovation. anicomply frees your production and sets a new industry standard.
Current Challenges in Pharma and Life Science
- Volatile Demand & Uncertain Markets
Fluctuating needs, crises, shortened product cycles - Shift from Blockbusters to Specialized Therapies
Biologics, ATMPs, orphan drugs with smaller batch sizes - Technological Transformation in Manufacturing
Single use, modular facilities, digitalization and automation - Fragile Global Supply Chains
API dependencies, geopolitical risks, need for reshoring - Increasing Time to Market Pressure
Faster development, tight launch windows, intense competition - High Economic Pressure
Price pressure, generics/biosimilars, focus on efficiency and scalability
CDMO/CMO Requirements & Data Exchange
Regulatory Requirements & Digitalization
- The goal is higher product quality, better data integrity, and complete traceability.
Increasing Regulatory Complexity
Need for Flexible Production Systems
The Evolution of EBR Systems
From paper chaos through digital bottlenecks to an agile future with anicomply
Yesterday
The struggle with paper
- Months to years for recipe changes
- Manual transfers = error sources
- Endless validation cycles
- Frustrated teams
Today
- Weeks for simple changes
- Expensive licenses & external specialists
- Vendor lock-in ("golden cage")
- Compliance risks
Tomorrow
anicomply - Agile & Fast
- Minutes instead of months
- Word-native EBR - familiar tools
- 80-90% changes without vendor
- Delta validation
Yesterday: The struggle with paper and complex systems
Remember when recipe changes took many months or even years? Every step – from drafting in Word to manually re-entering into a bulky EBR system to endless validation cycles – was an error source and a time drain. The result: high costs, frustrated teams, and innovation moving at walking speed.
Electronic Batch Record (EBR) Software Comparison
| Criterion (semantic keywords) | Classic MES (EBR‑module) | Generic Low‑Code App Builder | anicomply (Word‑native EBR‑platform) |
|---|---|---|---|
| Change cycle time (recipe change speed) | Weeks–Months | Days–Weeks | Minutes–Hours (rapid recipe change) |
| Modeling effort (workflow authoring) | Specialist training & vendor scripting | Abstract visual modeling canvas | Familiar Microsoft Word® document structuring |
| Audit trail & 21 CFR Part 11 | Partially add-on / fragmented | Limited / custom scripts | Native, immutable audit trail + electronic signatures |
| Vendor lock / portability | High (proprietary data model) | Medium | Low – portable Word-based source assets |
| Domain autonomy (domain-driven changes) | Low (external specialists) | Medium | High – 80–90% changes by process owners |
| Validation overhead (cycle reduction potential) | High (rebuild & regression) | Medium | Reduced – delta validation approach |
| GxP compliance alignment | Broad, but cumbersome rollout | Generic, requires customization | Pre-shaped for GxP / Part 11 from the start |
| Learning curve (time to productivity) | Long (training cycles) | Medium | Short – leverages existing Word skills |
| Total Cost of Ownership (TCO drivers) | Licenses + customization services | Platform + internal configuration time | Lean subscription + minimal change services |
| Upgrade friction (version changes) | High (dependency cascade) | Medium | Low – lightweight layer |
How a leading chemical company made Pharma 4.0 a reality with anicomply
Pharma 4.0 is fundamentally transforming production: smaller batches, faster adaptation to market needs, and a variety of products on a single line. With anicomply, the breakthrough was achieved – processes were digitized in compliance with GxP, compliance was ensured, and the foundation for future-proof production was established. We fulfill not only the requirements of Pharma 4.0, but also many other regulatory and operational standards.
FAQ – Decision Accelerators
Audit trail, versioning, electronic signatures and role model are core features.
No. It offloads the EBR/recipe area without duplicating core MES functions.
In pilot setups usually under 2 hours including approval stage.
Less modeling effort, regulatory pre-shaped data model, no proprietary vendor lock structure.